<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39253580</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2392</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in endocrinology</Title><ISOAbbreviation>Front Endocrinol (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Association of COVID-19 infection and the risk of new incident diabetes: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1429848</StartPage><MedlinePgn>1429848</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1429848</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fendo.2024.1429848</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">As the world population recovers from the COVID-19 infection, a series of acute sequelae emerge including new incident diabetes. However, the association between COVID-19 infection and new incident diabetes is not fully understood. We purpose to determine the risk of new incident diabetes after COVID-19 infection.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">PubMed, Embase, and Cochrane Library were used as databases to search for cohort studies published from database inception to February 4, 2024. Two reviewers independently conducted the study screening, data extraction, and risk of bias assessment. A random-effects model was adopted to pool the hazard ratio (HR) with corresponding 95% confidence intervals (CI). Subgroup analysis was conducted to explore the potential influencing factors.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 20 cohort studies with over 60 million individuals were included. The pooling analysis illustrates the association between COVID-19 infection and an increased risk of new incident diabetes (HR = 1.46; 95% CI: 1.38-1.55). In subgroup analysis, the risk of type 1 diabetes was HR=1.44 (95% CI: 1.13-1.82), and type 2 diabetes was HR=1.47 (95% CI: 1.36-1.59). A slightly higher risk of diabetes was found in males (HR=1.37; 95% CI: 1.30-1.45) than in females (HR=1.29; 95% CI: 1.22-1.365). The risk of incident diabetes is associated with hospitalization: non-hospitalized patients have an HR of 1.16 (95% CI: 1.07-1.26), normal hospitalized patients have an HR of 2.15 (95% CI: 1.33-3.49), and patients receiving intensive care have the highest HR of 2.88 (95% CI: 1.73-4.79).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">COVID-19 infection is associated with an elevated risk of new incident diabetes. Patients ever infected with COVID-19 should be recognized as a high-risk population with diabetes.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION" NlmCategory="UNASSIGNED">https://www.crd.york.ac.uk/prospero, identifier CRD42024522050.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Zhou, Wang and Xu.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jingye</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>International Medical College, Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Life Sciences, University of Leicester, Leicester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yuzhu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>International Medical College, Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Life Sciences, University of Leicester, Leicester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Ruolan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>International Medical College, Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Life Sciences, University of Leicester, Leicester, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Endocrinol (Lausanne)</MedlineTA><NlmUniqueID>101555782</NlmUniqueID><ISSNLinking>1664-2392</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">diabetes mellitus</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">public health</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>10</Day><Hour>4</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39253580</ArticleId><ArticleId IdType="pmc">PMC11381376</ArticleId><ArticleId IdType="doi">10.3389/fendo.2024.1429848</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Harcourt BE, Penfold SA, Forbes JM. Coming full circle in diabetes mellitus: from complications to initiation. Nat Rev Endocrinol. (2013) 9:113&#x2013;23. doi:&#xa0;10.1038/nrendo.2012.236</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2012.236</ArticleId><ArticleId IdType="pubmed">23296171</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet (London England). (2017) 389:2239&#x2013;51. doi:&#xa0;10.1016/S0140-6736(17)30058-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)30058-2</ArticleId><ArticleId IdType="pubmed">28190580</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam S, Hasan MK, Neaz S, Hussain N, Hossain MF, Rahman T. Diabetes mellitus: insights from epidemiology, biochemistry, risk factors, diagnosis, complications and comprehensive management. Diabetology. (2021) 2:36&#x2013;50. doi:&#xa0;10.3390/diabetology2020004</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diabetology2020004</ArticleId></ArticleIdList></Reference><Reference><Citation>Rey-Re&#xf1;ones C, Martinez-Torres S, Mart&#xed;n-Luj&#xe1;n FM, Pericas C, Redondo A, Vilaplana-Carnerero C, et al. . Type 2 diabetes mellitus and COVID-19: A narrative review. Biomedicines. (2022) 10:2089. doi:&#xa0;10.3390/biomedicines10092089</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10092089</ArticleId><ArticleId IdType="pmc">PMC9495673</ArticleId><ArticleId IdType="pubmed">36140191</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima-Mart&#xed;nez MM, Carrera Boada C, Madera-Silva MD, Mar&#xed;n W, Contreras M. COVID-19 and diabetes: A bidirectional relationship. Clinica e investigacion en arteriosclerosis: publicacion oficial la Sociedad Espanola Arterioscler. (2021) 33:151&#x2013;7. doi:&#xa0;10.1016/j.arteri.2020.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arteri.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7598432</ArticleId><ArticleId IdType="pubmed">33303218</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Misra A. Post COVID-19 syndrome (&#x201c;Long COVID&#x201d;) and diabetes: challenges in diagnosis and management. Diabetes Metab syndrome. (2021) 15:102235. doi:&#xa0;10.1016/j.dsx.2021.102235</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.102235</ArticleId><ArticleId IdType="pmc">PMC8317446</ArticleId><ArticleId IdType="pubmed">34384972</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao H, Baranova A, Wei X, Wang C, Zhang F. Bidirectional causal associations between type 2 diabetes and COVID-19. J Med Virol. (2023) 95:e28100. doi:&#xa0;10.1002/jmv.28100</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28100</ArticleId><ArticleId IdType="pmc">PMC9538258</ArticleId><ArticleId IdType="pubmed">36029131</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T, Tapp RJ, Cooper ME, Zimmet P. Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes. Diabetes Metab. (2021) 47:101204. doi:&#xa0;10.1016/j.diabet.2020.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabet.2020.10.002</ArticleId><ArticleId IdType="pmc">PMC7591867</ArticleId><ArticleId IdType="pubmed">33129968</ArticleId></ArticleIdList></Reference><Reference><Citation>Khunti K, Del Prato S, Mathieu C, Kahn SE, Gabbay RA, Buse JB. COVID-19, hyperglycemia, and new-onset diabetes. Diabetes Care. (2021) 44:2645&#x2013;55. doi:&#xa0;10.2337/dc21-1318</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc21-1318</ArticleId><ArticleId IdType="pmc">PMC8669536</ArticleId><ArticleId IdType="pubmed">34625431</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Y, Jiao B, Qu L, Yang D, Liu R. The development of COVID-19 treatment. Front Immunol. (2023) 14:1125246. doi:&#xa0;10.3389/fimmu.2023.1125246</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1125246</ArticleId><ArticleId IdType="pmc">PMC9909293</ArticleId><ArticleId IdType="pubmed">36776881</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization . Statement on the fifteenth meeting of the IHR, (2005) Emergency Committee on the COVID-19 pandemic (2023). Available online at: https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-%282005%29-emergency-committee-regarding-the-coronavirus-disease-%28covid-19%29-pandemic (Accessed 11 April 2024).</Citation></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. (2023) 21:133&#x2013;46. doi:&#xa0;10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. (2021) 594:259&#x2013;64. doi:&#xa0;10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T, Kapoor N, Cao Y, Tapp RJ, Zimmet P. Proportion of newly diagnosed diabetes in COVID-19 patients: A systematic review and meta-analysis. Diabetes Obes Metab. (2021) 23:870&#x2013;4. doi:&#xa0;10.1111/dom.14269</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14269</ArticleId><ArticleId IdType="pmc">PMC7753574</ArticleId><ArticleId IdType="pubmed">33245182</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T, Mei Q, Zhang Z, Walline JH, Liu Y, Zhu H, et al. . Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis. BMC Med. (2022) 20:444. doi:&#xa0;10.1186/s12916-022-02656-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02656-y</ArticleId><ArticleId IdType="pmc">PMC9666960</ArticleId><ArticleId IdType="pubmed">36380329</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai H, Yang M, Sun M, Pan B, Wang Q, Wang J, et al. . Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis. Metabolism: Clin Exp. (2022) 137:155330. doi:&#xa0;10.1016/j.metabol.2022.155330</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2022.155330</ArticleId><ArticleId IdType="pmc">PMC9546784</ArticleId><ArticleId IdType="pubmed">36220361</ArticleId></ArticleIdList></Reference><Reference><Citation>Zareini B, S&#xf8;rensen KK, Eiken PA, Fischer TK, Kristensen PL, Lendorf ME, et al. . Association of COVID-19 and development of type 1 diabetes: A Danish nationwide register study. Diabetes Care. (2023) 46:1477&#x2013;82. doi:&#xa0;10.2337/dc23-0428</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc23-0428</ArticleId><ArticleId IdType="pubmed">37276529</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Systematic Rev. (2021) 10:89. doi:&#xa0;10.1186/s13643-021-01626-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-021-01626-4</ArticleId><ArticleId IdType="pmc">PMC8008539</ArticleId><ArticleId IdType="pubmed">33781348</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor KS, Mahtani KR, Aronson JK. Summarising good practice guidelines for data extraction for systematic reviews and meta-analysis. BMJ Evidence-Based Med. (2021) 26:88&#x2013;90. doi:&#xa0;10.1136/bmjebm-2020-111651</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjebm-2020-111651</ArticleId><ArticleId IdType="pubmed">33632720</ArticleId></ArticleIdList></Reference><Reference><Citation>
Wells GA, Shea B, O&#x2019;Connell D, Peterson J, Welch V, Losos M, et al. . The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses (2014). Oxford. Available online at: http://www.evidencebasedpublichealth.de/download/Newcastle_Ottowa_Scale_Pope_Bruce.pdf (Accessed March 12, 2023).</Citation></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med. (2022) 28:2398&#x2013;405. doi:&#xa0;10.1038/s41591-022-02051-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. (2022) 10:311&#x2013;21. doi:&#xa0;10.1016/S2213-8587(22)00044-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Aslam B, Naeem B, Aman S, Majeed M. Association between covid-19 and diabetes mellitus. Pakistan J Med Health Sci. (2023) 17:117&#x2013;9. doi:&#xa0;10.53350/pjmhs2023174117</Citation><ArticleIdList><ArticleId IdType="doi">10.53350/pjmhs2023174117</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett CE, Koyama AK, Alvarez P, Chow W, Lundeen EA, Perrine CG, et al. . Risk for newly diagnosed diabetes &gt;30 days after SARS-CoV-2 infection among persons aged &lt;18 years - United States, March 1, 2020-June 28, 2021. MMWR. Morbidity Mortality Weekly Rep. (2022) 71:59&#x2013;65. doi:&#xa0;10.15585/mmwr.mm7102e2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7102e2</ArticleId><ArticleId IdType="pmc">PMC8757617</ArticleId><ArticleId IdType="pubmed">35025851</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JH, Kim KM, Song K, Seo GH. Risk for Newly Diagnosed Type 2 Diabetes Mellitus after COVID-19 among Korean Adults: A Nationwide Matched Cohort Study. Endocrinol Metab (Seoul Korea). (2023) 38:245&#x2013;52. doi:&#xa0;10.3803/EnM.2023.1662</Citation><ArticleIdList><ArticleId IdType="doi">10.3803/EnM.2023.1662</ArticleId><ArticleId IdType="pmc">PMC10164491</ArticleId><ArticleId IdType="pubmed">37016490</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty SE, Guo Y, Heath K, Dasmari&#xf1;as MC, Jubilo KG, Samranvedhya J, et al. . Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ (Clinical Res ed.). (2021) 373:n1098. doi:&#xa0;10.1136/bmj.n1098</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Shu T, Zhu R, Yang F, Zhang B, Lai X. The long-term effect of COVID-19 disease severity on risk of diabetes incidence and the near 1-year follow-up outcomes among postdischarge patients in Wuhan. J Clin Med. (2022) 11:3094. doi:&#xa0;10.3390/jcm11113094</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11113094</ArticleId><ArticleId IdType="pmc">PMC9181214</ArticleId><ArticleId IdType="pubmed">35683480</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendall EK, Olaker VR, Kaelber DC, Xu R, Davis PB. Association of SARS-coV-2 infection with new-onset type 1 diabetes among pediatric patients from 2020 to 2021. JAMA Network Open. (2022) 5:e2233014. doi:&#xa0;10.1001/jamanetworkopen.2022.33014</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.33014</ArticleId><ArticleId IdType="pmc">PMC9508649</ArticleId><ArticleId IdType="pubmed">36149658</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan AC, Ebinger JE, Botting P, Navarrette J, Claggett B, Cheng S. Association of COVID-19 vaccination with risk for incident diabetes after COVID-19 infection. JAMA Network Open. (2023) 6:e2255965. doi:&#xa0;10.1001/jamanetworkopen.2022.55965</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.55965</ArticleId><ArticleId IdType="pmc">PMC9929690</ArticleId><ArticleId IdType="pubmed">36787145</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu JY, Wilson J, Hou W, Fleysher R, Herold BC, Herold KC, et al. . Incidence of new-onset in-hospital and persistent diabetes in COVID-19 patients: comparison with influenza. EBioMedicine. (2023) 90:104487. doi:&#xa0;10.1016/j.ebiom.2023.104487</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104487</ArticleId><ArticleId IdType="pmc">PMC9970376</ArticleId><ArticleId IdType="pubmed">36857969</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeigue PM, McGurnaghan S, Blackbourn L, Bath LE, McAllister DA, Caparrotta TM, et al. . Relation of incident type 1 diabetes to recent COVID-19 infection: cohort study using e-health record linkage in Scotland. Diabetes Care. (2023) 46:921&#x2013;8. doi:&#xa0;10.2337/dc22-0385</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc22-0385</ArticleId><ArticleId IdType="pubmed">35880797</ArticleId></ArticleIdList></Reference><Reference><Citation>Naveed Z, Vel&#xe1;squez Garc&#xed;a HA, Wong S, Wilton J, McKee G, Mahmood B, et al. . Association of COVID-19 infection with incident diabetes. JAMA Network Open. (2023) 6:e238866. doi:&#xa0;10.1001/jamanetworkopen.2023.8866</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.8866</ArticleId><ArticleId IdType="pmc">PMC10114057</ArticleId><ArticleId IdType="pubmed">37071420</ArticleId></ArticleIdList></Reference><Reference><Citation>Noorzae R, Junker TG, Hviid AP, Wohlfahrt J, Olsen SF. Risk of type 1 diabetes in children is not increased after SARS-coV-2 infection: A nationwide prospective study in Denmark. Diabetes Care. (2023) 46:1261&#x2013;4. doi:&#xa0;10.2337/dc22-2351</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc22-2351</ArticleId><ArticleId IdType="pubmed">37058353</ArticleId></ArticleIdList></Reference><Reference><Citation>Qeadan F, Tingey B, Egbert J, Pezzolesi MG, Burge MR, Peterson KA, et al. . The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: A nationwide cohort from the US using the Cerner Real-World Data. PloS One. (2022) 17:e0266809. doi:&#xa0;10.1371/journal.pone.0266809</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0266809</ArticleId><ArticleId IdType="pmc">PMC9017888</ArticleId><ArticleId IdType="pubmed">35439266</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathmann W, Kuss O, Kostev K. Incidence of newly diagnosed diabetes after Covid-19. Diabetologia. (2022) 65:949&#x2013;54. doi:&#xa0;10.1007/s00125-022-05670-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-022-05670-0</ArticleId><ArticleId IdType="pmc">PMC8923743</ArticleId><ArticleId IdType="pubmed">35292829</ArticleId></ArticleIdList></Reference><Reference><Citation>Reges O, Test T, Hoshen M, Cicurel A, Saliba W, Greenland P, et al. . Time-varying association of acute and post-acute COVID-19 with new-onset diabetes mellitus among hospitalized and non-hospitalized patients. BMJ Open Diabetes Res Care. (2023) 11:e003052. doi:&#xa0;10.1136/bmjdrc-2022-003052</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjdrc-2022-003052</ArticleId><ArticleId IdType="pmc">PMC9871869</ArticleId><ArticleId IdType="pubmed">36669793</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezel-Potts E, Douiri A, Sun X, Chowienczyk PJ, Shah AM, Gulliford MC. Cardiometabolic outcomes up to 12 months after COVID-19 infection: A matched cohort study in the UK. PloS Med. (2022) 19:e1004052. doi:&#xa0;10.1371/journal.pmed.1004052</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004052</ArticleId><ArticleId IdType="pmc">PMC9295991</ArticleId><ArticleId IdType="pubmed">35853019</ArticleId></ArticleIdList></Reference><Reference><Citation>
Soysal &#xc7;, Y&#x131;lmaz E. The effect of previous covid-19 infection on gestational diabetes mellitus. Gazi Med J. (2022) 33:397&#x2013;400. https://medicaljournal.gazi.edu.tr/index.php/GMJ/article/view/3594.</Citation></Reference><Reference><Citation>Zhang Y, Romieu-Hernandez A, Boehmer TK, Azziz-Baumgartner E, Carton TW, Gundlapalli AV, et al. . Association between SARS-CoV-2 infection and select symptoms and conditions 31 to 150 days after testing among children and adults. BMC Infect Dis. (2024) 24:181. doi:&#xa0;10.1186/s12879-024-09076-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-024-09076-8</ArticleId><ArticleId IdType="pmc">PMC10859007</ArticleId><ArticleId IdType="pubmed">38341566</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Li Y, Wang Z, Liu N, He L, Zhang H. Increased risk of new-onset diabetes in patients with COVID-19: a systematic review and meta-analysis. Front Public Health. (2023) 11:1170156. doi:&#xa0;10.3389/fpubh.2023.1170156</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1170156</ArticleId><ArticleId IdType="pmc">PMC10248182</ArticleId><ArticleId IdType="pubmed">37304092</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellia C, Andreadi A, D&#x2019;Ippolito I, Scola L, Barraco S, Meloni M, et al. . Prevalence and risk of new-onset diabetes mellitus after COVID-19: a systematic review and meta-analysis. Front Endocrinol. (2023) 14:1215879. doi:&#xa0;10.3389/fendo.2023.1215879</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2023.1215879</ArticleId><ArticleId IdType="pmc">PMC10507325</ArticleId><ArticleId IdType="pubmed">37732118</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CT, Lidsky PV, Xiao Y, Lee IT, Cheng R, Nakayama T, et al. . SARS-CoV-2 infects human pancreatic &#x3b2; cells and elicits &#x3b2; cell impairment. Cell Metab. (2021) 33:1565&#x2013;1576.e5. doi:&#xa0;10.1016/j.cmet.2021.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.05.013</ArticleId><ArticleId IdType="pmc">PMC8130512</ArticleId><ArticleId IdType="pubmed">34081912</ArticleId></ArticleIdList></Reference><Reference><Citation>Accili D. Can COVID-19 cause diabetes? Nat Metab. (2021) 3:123&#x2013;5. doi:&#xa0;10.1038/s42255-020-00339-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-020-00339-7</ArticleId><ArticleId IdType="pmc">PMC8892570</ArticleId><ArticleId IdType="pubmed">33432203</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusev E, Sarapultsev A, Solomatina L, Chereshnev V. SARS-coV-2-specific immune response and the pathogenesis of COVID-19. Int J Mol Sci. (2022) 23:1716. doi:&#xa0;10.3390/ijms23031716</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031716</ArticleId><ArticleId IdType="pmc">PMC8835786</ArticleId><ArticleId IdType="pubmed">35163638</ArticleId></ArticleIdList></Reference><Reference><Citation>Fignani D, Licata G, Brusco N, Nigi L, Grieco GE, Marselli L, et al. . SARS-coV-2 receptor angiotensin I-converting enzyme type 2 (ACE2) is expressed in human pancreatic &#x3b2;-cells and in the human pancreas microvasculature. Front Endocrinol. (2020) 11:596898. doi:&#xa0;10.3389/fendo.2020.596898</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.596898</ArticleId><ArticleId IdType="pmc">PMC7691425</ArticleId><ArticleId IdType="pubmed">33281748</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Long X, Zhang B, Zhang W, Chen X, Zhang Z. ACE2 expression in pancreas may cause pancreatic damage after SARS-coV-2 infection. Clin Gastroenterol Hepatol. (2020) 18:2128&#x2013;2130.e2. doi:&#xa0;10.1016/j.cgh.2020.04.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2020.04.040</ArticleId><ArticleId IdType="pmc">PMC7194639</ArticleId><ArticleId IdType="pubmed">32334082</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta diabetologica. (2010) 47:193&#x2013;9. doi:&#xa0;10.1007/s00592-009-0109-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00592-009-0109-4</ArticleId><ArticleId IdType="pmc">PMC7088164</ArticleId><ArticleId IdType="pubmed">19333547</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Guo H, Wang G, Zhai J, Du B. COVID-19 as a trigger for type 1 diabetes. J Clin Endocrinol Metab. (2023) 108:2176&#x2013;83. doi:&#xa0;10.1210/clinem/dgad165</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgad165</ArticleId><ArticleId IdType="pubmed">36950864</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller JA, Gro&#xdf; R, Conzelmann C, Kr&#xfc;ger J, Merle U, Steinhart J, et al. . SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat Metab. (2021) 3:149&#x2013;65. doi:&#xa0;10.1038/s42255-021-00347-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00347-1</ArticleId><ArticleId IdType="pubmed">33536639</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock C, Richter S, Berger I, Barovic M, Schmid J, Schubert U, et al. . Viral infiltration of pancreatic islets in patients with COVID-19. Nat Commun. (2021) 12:3534. doi:&#xa0;10.1038/s41467-021-23886-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23886-3</ArticleId><ArticleId IdType="pmc">PMC8192507</ArticleId><ArticleId IdType="pubmed">34112801</ArticleId></ArticleIdList></Reference><Reference><Citation>Coate KC, Cha J, Shrestha S, Wang W, Gon&#xe7;alves LM, Alma&#xe7;a J, et al. . SARS-coV-2 cell entry factors ACE2 and TMPRSS2 are expressed in the microvasculature and ducts of human pancreas but are not enriched in &#x3b2; Cells. Cell Metab. (2020) 32:1028&#x2013;1040.e4. doi:&#xa0;10.1016/j.cmet.2020.11.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.11.006</ArticleId><ArticleId IdType="pmc">PMC7664344</ArticleId><ArticleId IdType="pubmed">33207245</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusmartseva I, Wu W, Syed F, van der Heide V, Jorgensen M, Joseph P, et al. . Expression of SARS-coV-2 entry factors in the pancreas of normal organ donors and individuals with COVID-19. Cell Metab. (2020) 32:1041&#x2013;1051.e6. doi:&#xa0;10.1016/j.cmet.2020.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.11.005</ArticleId><ArticleId IdType="pmc">PMC7664515</ArticleId><ArticleId IdType="pubmed">33207244</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanza K, Perez LG, Costa LB, Cordeiro TM, Palmeira VA, Ribeiro VT, et al. . Covid-19: the renin-angiotensin system imbalance hypothesis. Clin Sci (London England: 1979). (2020) 134:1259&#x2013;64. doi:&#xa0;10.1042/CS20200492</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20200492</ArticleId><ArticleId IdType="pmc">PMC7276636</ArticleId><ArticleId IdType="pubmed">32507883</ArticleId></ArticleIdList></Reference><Reference><Citation>Jandeleit-Dahm KA, Tikellis C, Reid CM, Johnston CI, Cooper ME. Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes. J hypertension. (2005) 23:463&#x2013;73. doi:&#xa0;10.1097/01.hjh.0000160198.05416.72</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.hjh.0000160198.05416.72</ArticleId><ArticleId IdType="pubmed">15716683</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehrabadi ME, Hemmati R, Tashakor A, Homaei A, Yousefzadeh M, Hemati K, et al. . Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity. Biomedicine pharmacotherapy = Biomedecine pharmacotherapie. (2021) 137:111363. doi:&#xa0;10.1016/j.biopha.2021.111363</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.111363</ArticleId><ArticleId IdType="pmc">PMC7862910</ArticleId><ArticleId IdType="pubmed">33582450</ArticleId></ArticleIdList></Reference><Reference><Citation>Melvin WJ, Audu CO, Davis FM, Sharma SB, Joshi A, DenDekker A, et al. . Coronavirus induces diabetic macrophage-mediated inflammation via SETDB2. Proc Natl Acad Sci United States America. (2021) 118:e2101071118. doi:&#xa0;10.1073/pnas.2101071118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2101071118</ArticleId><ArticleId IdType="pmc">PMC8463849</ArticleId><ArticleId IdType="pubmed">34479991</ArticleId></ArticleIdList></Reference><Reference><Citation>Sosale A, Sosale B, Kesavadev J, Chawla M, Reddy S, Saboo B, et al. . Steroid use during COVID-19 infection and hyperglycemia - What a physician should know. Diabetes Metab syndrome. (2021) 15:102167. doi:&#xa0;10.1016/j.dsx.2021.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.06.004</ArticleId><ArticleId IdType="pmc">PMC8189750</ArticleId><ArticleId IdType="pubmed">34186344</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabbour RM, Hallit S, Saliby R, Baydoun AEK, Nakhoul N. Is COVID-19 incriminated in new onset type 2 diabetes mellitus in Lebanese adults? BMC Res Notes. (2023) 16:176. doi:&#xa0;10.1186/s13104-023-06454-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13104-023-06454-4</ArticleId><ArticleId IdType="pmc">PMC10439538</ArticleId><ArticleId IdType="pubmed">37596697</ArticleId></ArticleIdList></Reference><Reference><Citation>Keng SL, Stanton MV, Haskins LB, Almenara CA, Ickovics J, Jones A, et al. . COVID-19 stressors and health behaviors: A multilevel longitudinal study across 86 countries. Prev Med Rep. (2022) 27:101764. doi:&#xa0;10.1016/j.pmedr.2022.101764</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmedr.2022.101764</ArticleId><ArticleId IdType="pmc">PMC8928741</ArticleId><ArticleId IdType="pubmed">35313454</ArticleId></ArticleIdList></Reference><Reference><Citation>Koc HC, Xiao J, Liu W, Li Y, Chen G. Long COVID and its management. Int J Biol Sci. (2022) 18:4768&#x2013;80. doi:&#xa0;10.7150/ijbs.75056</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.75056</ArticleId><ArticleId IdType="pmc">PMC9305273</ArticleId><ArticleId IdType="pubmed">35874958</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Ferran M, de la Gu&#xed;a-Galipienso F, Sanchis-Gomar F, Pareja-Galeano H. Metabolic impacts of confinement during the COVID-19 pandemic due to modified diet and physical activity habits. Nutrients. (2020) 12:1549. doi:&#xa0;10.3390/nu12061549</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12061549</ArticleId><ArticleId IdType="pmc">PMC7352228</ArticleId><ArticleId IdType="pubmed">32466598</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, et al. . Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. (2020) 8:152. doi:&#xa0;10.3389/fpubh.2020.00152</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00152</ArticleId><ArticleId IdType="pmc">PMC7201103</ArticleId><ArticleId IdType="pubmed">32411652</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X, Chen J, Wang X, Zhang F, Liu Y. Age- and gender-related difference of ACE2 expression in rat lung. Life Sci. (2006) 78:2166&#x2013;71. doi:&#xa0;10.1016/j.lfs.2005.09.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2005.09.038</ArticleId><ArticleId IdType="pmc">PMC7094566</ArticleId><ArticleId IdType="pubmed">16303146</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al. . Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine. (2022) 53:101624. doi:&#xa0;10.1016/j.eclinm.2022.101624</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>